Literature DB >> 1115795

Action of heparin on thrombin-antithrombin reaction.

R Machovich, G Blaskó, L A Pálos.   

Abstract

Thrombin partially purified from bovine plasma can be inactivated at 60 degress C. In the presence of 10 units of heparin the extent of inactivation decreases. When thrombin and heparin are mixed and incubated for 5 min at 0 degrees C before gel filtration on Sephadex G-200, thrombin with heparin is eluted prior to either thrombin or heparin laone. These data suggest a complex formation between thrombin and heparin. Immobilized heparin binds thrombin. The enzyme can be eluted with 0.05 M Tris-HCl buffer, pH 7.3, containing an ion mixture of Na+, K+ and Ca2+ at 73, 3 and 11 mM, respectively, at 0 degrees C and with 0.05 M Tris-HCl buffer, pH 7.3, containing 0.5 M NaCl at 20 degrees C. During the same chromatographic procedure, antithrombin-III (heparin cofactor) partially purified from human plasma is eluted with 0.05 M Tris-HCl buffer, pH 7.3, at 0 degrees C as well as 20 degrees C. Although, as described in the literature, heparin binds to antithrombin, our findings suggest another possibility, i.e. that the binding of heparin to thrombin induces a conformational change in the enzyme facilitating a complex formation between thrombin and antithrombin-III.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115795     DOI: 10.1016/0005-2795(75)90022-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  New heparin-like insoluble materials: part I.

Authors:  C Fougnot; J Jozefonvicz; M Samama; L Bara
Journal:  Ann Biomed Eng       Date:  1979       Impact factor: 3.934

2.  Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.

Authors:  P Lollar; W G Owen
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

Review 3.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

4.  Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma.

Authors:  N E Stathakis; M W Mosesson
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

5.  Pulmonary embolism: a review of medical treatment.

Authors:  W Livingstone
Journal:  Can Fam Physician       Date:  1976-12       Impact factor: 3.275

6.  Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.

Authors:  R Machovich; P I Bauer; P Arányi; E Kecskés; K G Büki; I Horváth
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

7.  Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

Authors:  D A Lane; J Denton; A M Flynn; L Thunberg; U Lindahl
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

8.  Binding of platelet factor 4 to heparin oligosaccharides.

Authors:  J Denton; D A Lane; L Thunberg; A M Slater; U Lindahl
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

9.  Effect of heparin on thrombin inactivation by antithrombin-III.

Authors:  R Machovich; P Arányi
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

10.  Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.

Authors:  R Machovich; A Borsodi; G Blaskó; S A Orakzai
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.